ArticleVeterinary medicine and science2018
Prevalence and risk factors for bluetongue in the State of São Paulo, Brazil.
Article in Veterinary medicine and science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 17 citations in OpenAlex.
- Knowledge mapping of risk mitigation measures against vector-borne diseases.EFSA journal. European Food Safety Authority · 2026Article
- National Seroprevalence and Risk Factors of Bluetongue Virus in Domestic Ruminants of Peru.Transboundary and emerging diseases · 2025Article
- Longitudinal seroepidemiological survey and risk factors for bluetongue virus infection in sheep in the state of Parana, Brazil, from 2014 to 2017.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- Article
- Bluetongue Virus Infections in Cattle Herds of Manabí Province of Ecuador.Pathogens (Basel, Switzerland) · 2021Article
- An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.The veterinary quarterly · 2020Review
- Type-specific seroprevalence of bluetongue in India during 2018 and 2019.Veterinary world · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bluetongue (BT), caused by Bluetongue virus (BTV), is a disease that affects ruminants such as cattle, sheep, goats and deer. BTV is transmitted by female midges of the genus Culicoides. In Brazil, information on the prevalence of BTV in cattle is limited, so the objective of this work was to identify BTV serotypes in cattle. The State of São Paulo was divided into seven cattle-producing regions, and in each of them, 300 cattle farms were randomly selected. One animal from each farm (out of a total of 1,598 farms) was selected and its sera tested by virus neutralization technique against BTV serotypes (1-24 and 26) for determining antibody titre. Moreover, for each sampled farm, an epidemiological questionnaire was submitted to verify the type of cattle production and the zootechnical and sanitary practices carried out, which could be associated with a higher risk of BTV infection. In this study, antibodies (percentage, [95% confidence interval]) were identified against 11 serotypes: BTV-1 (22.15%, [15.72-27.92]), BTV-2 (31.03%, [26.65-37.98]), BTV-3 (18.96%, [12.42-24.90]), BTV-4 (24.90% [19.41-29.12]), BTV-9 (6.82%, [1.45-11.72]), BTV-12 (7.50%, [2.82-12.51]), BTV-17 (23.90%, [17.35-29.35]), BTV-19 (10.20%, [4.62-5.56]), BTV-21 (30.66%, [25.00-36.00]), BTV-22 (12.14%, [5.91-18.55]), BTV-26 (57.00%, [51.41-63.59]). In this study, for the first time in Brazil serological evidence of the presence of serotypes BTV-2, BTV-9, BTV-21 and BTV-26 is reported. The variable 'new cattle entering herd' was considered a risk factor for the occurrence of infection (OR = 2.183, 95% CI = 1.6-2.9).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.